SBC Medical Group (NASDAQ:SBC) Shares Down 6.1% – Should You Sell?

by · The Markets Daily

SBC Medical Group Holdings Incorporated (NASDAQ:SBC – Get Free Report)’s share price dropped 6.1% on Friday. The stock traded as low as $5.40 and last traded at $5.3450. 82,177 shares traded hands during trading, a decline of 30% from the average daily volume of 117,536 shares. The stock had previously closed at $5.69.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on SBC. Weiss Ratings raised SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Wall Street Zen upgraded SBC Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Monday, October 5th. Finally, BTIG Research reiterated a “buy” rating and issued a $8.00 price objective on shares of SBC Medical Group in a research report on Thursday, August 13th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $8.50.

Check Out Our Latest Research Report on SBC Medical Group

SBC Medical Group Stock Down 6.7%

The stock has a market cap of $546.24 million, a price-to-earnings ratio of 11.31, a price-to-earnings-growth ratio of 2.49 and a beta of 0.56. The business’s 50 day moving average is $4.67 and its 200 day moving average is $3.76. The company has a debt-to-equity ratio of 0.09, a quick ratio of 3.27 and a current ratio of 3.31.

SBC Medical Group (NASDAQ:SBC – Get Free Report) last issued its earnings results on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The business had revenue of $49.19 million for the quarter, compared to analyst estimates of $45.37 million. Equities analysts expect that SBC Medical Group Holdings Incorporated will post 0.44 earnings per share for the current year.

Institutional Investors Weigh In On SBC Medical Group

A number of hedge funds have recently made changes to their positions in SBC. BlackRock Inc. acquired a new stake in SBC Medical Group during the second quarter worth approximately $2,846,000. Citadel Advisors LLC purchased a new stake in SBC Medical Group in the 2nd quarter worth approximately $446,000. Segall Bryant & Hamill LLC bought a new stake in shares of SBC Medical Group during the 1st quarter valued at about $340,000. Bank of New York Mellon Corp bought a new stake in shares of SBC Medical Group during the 2nd quarter worth $83,000. Finally, Central Pacific Bank Trust Division bought a new position in SBC Medical Group during the second quarter valued at approximately $74,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.

About SBC Medical Group

(Get Free Report)

SBC Medical Group Holdings Incorporated is a Japan-based healthcare services company focused on supporting aesthetic medicine and related medical institutions. Through its group companies, the business provides operational and management support designed to help clinics deliver cosmetic surgery, dermatology, and other elective medical services.

The company’s services include clinic management consulting, marketing, staff recruitment and training, procurement, information technology, and administrative support.

Recommended Stories